{"id":118457,"date":"2021-06-28T11:00:00","date_gmt":"2021-06-28T11:00:00","guid":{"rendered":"https:\/\/icrowdnewswire.com\/?p=2885728"},"modified":"2021-06-28T11:00:00","modified_gmt":"2021-06-28T11:00:00","slug":"the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30","status":"publish","type":"post","link":"http:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/","title":{"rendered":"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30)"},"content":{"rendered":"<p><img decoding=\"async\" width=\"300\" height=\"300\" src=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png\" class=\"webfeedsFeaturedVisual wp-post-image\" alt=\"\" loading=\"lazy\" style=\"display: block; margin-bottom: 5px; clear:both;max-width: 100%;\" link_thumbnail=\"\" \/><\/p>\n<p><span style=\"font-weight: 400;\"><img decoding=\"async\" loading=\"lazy\" class=\"aligncenter\" src=\"https:\/\/beta-kiosk.icrowdnewswire.com\/assets\/source\/users\/delveinsight\/Iron-Deficiency-Anemia-Market-Insights-01.jpg?1624869935741\" alt=\"Iron-Deficiency-Anemia-Market-Insights-01\" width=\"650\" height=\"341\" \/><\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">The <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia Market Report<\/strong><\/a><span style=\"font-weight: 400;\"> from DelveInsight provides an in-depth understanding of Iron Deficiency Anemia, historical and forecasted epidemiology, as well as Iron Deficiency Anemia market patterns in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.<\/span><\/p>\n<p><strong>Some of the Key Highlights from the <\/strong><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia Market Report<\/strong><\/a><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The US population was analysed between 1999 and 2018, and dietary iron consumption decreased by <\/span><strong>6.6 percent and 9.5 percent<\/strong><span style=\"font-weight: 400;\"> for male and female adults, respectively, according to Sun and Wiever (2021). The incidence of estimated anemia increased by <\/span><strong>10.5 percent to 10.6 percent<\/strong><span style=\"font-weight: 400;\"> in the United States, based on age and gender.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">According to Warner and Kamran (2020), <\/span><strong>1 percent<\/strong><span style=\"font-weight: 400;\"> of men under 50 in the United States have Iron Deficiency Anemia. In the United States, <\/span><strong>ten percent<\/strong><span style=\"font-weight: 400;\"> of women of childbearing age are Iron deficient due to menstrual losses, whereas <\/span><strong>nine percent<\/strong><span style=\"font-weight: 400;\"> of children aged 12 to 36 months are iron deficient, with <\/span><strong>one-third<\/strong><span style=\"font-weight: 400;\"> of these children developing anemia.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Pipeline therapies in the Iron Deficiency Anemia market are <\/span><strong>Vadadustat<\/strong><span style=\"font-weight: 400;\"> (Akebia Therapeutics), <\/span><strong>Daprodustat<\/strong><span style=\"font-weight: 400;\"> (GlaxoSmithKline), <\/span><strong>IHAT-02<\/strong><span style=\"font-weight: 400;\"> (Nemysis), <\/span><strong>MPB-1514<\/strong><span style=\"font-weight: 400;\"> (MegaPro Biomedical), and others.<\/span><\/li>\n<li style=\"font-weight: 400;\"><strong>Akebia Therapeutics, GlaxoSmithKline, Nemysis, MegaPro Biomedical,<\/strong><span style=\"font-weight: 400;\"> among others are the major players in the Iron Deficiency Anemia market.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The rise in Iron Deficiency Anemia market size is a direct result of the increase in the 7MM\u00a0 Iron Deficiency Anemia cases.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">The\u00a0 Iron Deficiency Anemia therapeutic market is expected to expand as disease understanding improves and new therapies enter the market.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Request sample @<\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>Iron Deficiency Anemia Market Insights<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Current clinical practices, new medications, Iron Deficiency Anemia market share of individual therapies, current and forecasted Iron Deficiency Anemia market Size from 2018 to 2030 segmented by seven major markets are all covered in the <\/span><strong>Iron Deficiency Anemia market report.<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia: Disease Overview<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Anaemia occurs when the number of red blood cells or the concentration of haemoglobin is lower than average. Men over 15 years of age have haemoglobin (Hb) concentrations below 13 g\/dl, non-pregnant women over 15 years of age have Hb concentrations below 12 g\/dl, and pregnant women have Hb concentrations below 11 g\/dl. There would be a reduced capacity of the blood to bring oxygen to the body&#8217;s tissues whether there are too few or abnormal red blood cells, or not enough haemoglobin.<\/span><\/p>\n<p><strong>Iron Deficiency Anemia Epidemiology Segmentation<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Anemia Total Prevalent Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Anemia Gender-Specific Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Anemia Age-Specific Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Anemia Severity-Specific Cases<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Anemia Total Diagnosed and Treated Cases<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Learn more about epidemiology @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia Epidemiology<\/strong><\/a><\/p>\n<p><strong>Iron Deficiency Anemia Treatment Landscape<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">The aim of treatment is to get Hb levels and red cell indices back to normal, as well as replenish iron reserves. Some of the current treatment options for Iron Deficiency Anemia are:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ferrous sulfate<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ferric citrate (Auryxia)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ferric carboxymaltose injection (Injectafer)<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ferric derisomaltose (Monoferric)<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Key pharmaceutical companies such as <\/span><strong>Akebia Therapeutics, GlaxoSmithKline, Nemysis, MegaPro Biomedical,<\/strong><span style=\"font-weight: 400;\"> and others are expected to launch new therapies in the Iron Deficiency Anemia market.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">The introduction of Vadadustat (Akebia Therapeutics), Daprodustat (GlaxoSmithKline), IHAT-02 (Nemysis), MPB-1514 (MegaPro Biomedical) are expected to give the Iron Deficiency Anemia market a significant boost in the forecast period 2021-30 in the 7MM.<\/span><\/p>\n<p><strong>Iron Deficiency Anemia Pipeline Therapies and Key Companies<\/strong><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Vadadustat: Akebia Therapeutics<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Daprodustat: GlaxoSmithKline<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">IHAT-02: Nemysis<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">MPB-1514: MegaPro Biomedical<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Get more details about emerging drugs @ <\/span><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Deficiency Anemia Pipeline Therapies and Major Companies<\/strong><\/a><\/p>\n<p><strong>Table of Contents<\/strong><\/p>\n<table style=\"border-collapse: collapse; width: 100%;\" border=\"1\">\n<tbody>\n<tr>\n<td style=\"width: 8.82349%;\">1.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Key Insights<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">2.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Market Overview at a Glance<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">3.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Executive Summary<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">4.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Organizations<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">5.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Patient Journey<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">6.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Disease Overview: Anemia<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">7.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Epidemiology and Patient Population<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">8.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Unmet Needs<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">9.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Emerging Therapies<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">10.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Market Outlook<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">11.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Market Drivers<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">12.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Market Barriers<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">13.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Anemia : Market access and Reimbursement<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">14.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">SWOT Analysis<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">15.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Case studies<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">16.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">KOL Views<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">17.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Appendix<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">18.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">Disclaimer<\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 8.82349%;\">19.<\/td>\n<td style=\"width: 91.1765%;\"><span style=\"font-weight: 400;\">About DelveInsight<\/span><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><span style=\"font-weight: 400;\">Know more about report offerings @<\/span><a href=\"https:\/\/www.delveinsight.com\/sample-request\/iron-deficiency-anemia-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>Iron Deficiency Anemia Market Outlook<\/strong><\/a><\/p>\n<p><strong>Related Reports<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/iron-overload-syndrome-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Iron Overload Syndrome Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Iron Overload Syndrome &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Iron Overload Syndrome, historical and forecasted epidemiology as well as the Iron Overload Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/somatotropin-deficiency-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Somatotropin Deficiency <\/strong><strong>\u00a0Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Somatotropin Deficiency <\/span><span style=\"font-weight: 400;\">Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Merck Serono, <\/strong><strong>Pfizer, Novo Nordisk, F. Hoffmann-La Roche, Eli Lilly, BioPartners,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/vitamin-a-deficiency-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Vitamin A Deficiency Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Vitamin A Deficiency Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Vitamin A Deficiency , historical and forecasted epidemiology as well as the Vitamin A Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/adult-growth-hormone-deficiency-aghd-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Adult Growth Hormone Deficiency Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Adult Growth Hormone Deficiency (AGHD) &#8211; Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Adult Growth Hormone Deficiency (AGHD), historical and forecasted epidemiology as well as the Adult Growth Hormone Deficiency (AGHD) market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/alpha-antitrypsin-deficiency-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Alpha- Antitrypsin Deficiency Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8216;Alpha- Antitrypsin Deficiency (AATD) &#8211; Market Insights, Epidemiology and Market Forecast-2028&#8217;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the disease, historical and forecasted epidemiology trends in the United States and EU5 (Germany, Spain, Italy, France and United Kingdom).<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/coagulation-factor-deficiency-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Coagulation Factor Deficiency Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Coagulation Factor Deficiency <\/span><span style=\"font-weight: 400;\">Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Sanofi, Biotest, Hoffmann-La Roche, AryoGen Pharmed Co., ICON plc.,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/pyruvate-kinase-deficiency-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Pyruvate Kinase Deficiency Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Pyruvate Kinase Deficiency- Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Pyruvate Kinase Deficiency , historical and forecasted epidemiology as well as the Pyruvate Kinase Deficiency market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/irritable-bowel-syndrome-ibs-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Irritable Bowel Syndrome Market\u00a0<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Irritable Bowel Syndrome <\/span><span style=\"font-weight: 400;\">Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Redhill Biopharma, Forest Pharmaceuticals, Inc., Bausch Health,<\/strong><span style=\"font-weight: 400;\"> among others.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/immunologic-deficiency-syndrome-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Immunologic Deficiency Syndrome Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight&#8217;s <\/span><strong>&#8220;Immunologic Deficiency Syndrome- Market Insights, Epidemiology, and Market Forecast-2030&#8221;<\/strong><span style=\"font-weight: 400;\"> report delivers an in-depth understanding of the Immunologic Deficiency Syndrome, historical and forecasted epidemiology as well as the Immunologic Deficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.<\/span><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/report-store\/aneurysmal-subarachnoid-hemorrhage-sah-market?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Aneurysmal Subarachnoid Hemorrhage <\/strong><strong>Market<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">Get comprehensive historical and forecast analysis of <\/span><span style=\"font-weight: 400;\">Aneurysmal Subarachnoid Hemorrhage <\/span><span style=\"font-weight: 400;\">Market, Epidemiological and Therapeutics market domain with a special focus on key companies such as <\/span><strong>Arbor Pharmaceuticals, Evgen Pharma, Idorsia Pharmaceuticals, Grace Therapeutics, Edge Therapeutics\/PDS Biotechnology Corporation, BIT Pharma, <\/strong><span style=\"font-weight: 400;\">among others.<\/span><\/p>\n<p><strong>Related Posts<\/strong><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/warm-autoimmune-ahemolytic-anemia-epidemiology-forecast\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Autoimmune Hemolytic Anemia Epidemiology Forecast<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/beta-thalassemia-market\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Beta Thalassemia Market<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/blog\/multiple-myeloma-market\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Multiple Myeloma Market\u00a0<\/strong><\/a><\/p>\n<p><a href=\"https:\/\/www.delveinsight.com\/consulting\/market-assessment-services?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"><strong>Get in touch with our Business executive for Competitive Insights, M&amp;A and Due Diligence<\/strong><\/a><strong> Services<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">About<\/span><a href=\"https:\/\/www.delveinsight.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>DelveInsight<\/strong><\/a><\/p>\n<p><span style=\"font-weight: 400;\">DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end to end comprehensive solutions to improve their performance.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform<\/span><a href=\"https:\/\/www.pharmdelve.com\/?utm_source=Icrowd&amp;utm_medium=pressrelease&amp;utm_campaign=spr\"> <strong>PharmDelve<\/strong><span style=\"font-weight: 400;\">.<\/span><\/a><\/p>\n<p><strong>Contact Us\u00a0<\/strong><\/p>\n<p><span style=\"font-weight: 400;\">Sandeep Joshi\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">info@delveinsight.com\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">+1(919)321-6187\u00a0<\/span><\/p>\n<p><a href=\"http:\/\/www.delveinsight.com\"><span style=\"font-weight: 400;\">www.delveinsight.com<\/span><\/a><\/p>\n<p><strong>Connect With Us at:<\/strong><\/p>\n<p><a href=\"https:\/\/www.linkedin.com\/company\/delveinsight-business-research-llp\/\"><strong>LinkedIn<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/www.facebook.com\/delveinsightindia\/\"> <strong>Facebook<\/strong><\/a> <strong>|<\/strong><a href=\"https:\/\/twitter.com\/delve_insight\"> <strong>Twitter<\/strong><\/a><\/p>\n<p class=\"tags\">Tags: <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-companies\/\" rel=\"tag\">Iron Deficiency Anemia Companies<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-drugs\/\" rel=\"tag\">Iron Deficiency Anemia Drugs<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-market\/\" rel=\"tag\">Iron Deficiency Anemia Market<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-icd10\/\" rel=\"tag\">Iron Deficiency Anemia ICD10<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-causes\/\" rel=\"tag\">Iron Deficiency Anemia Causes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-treatment\/\" rel=\"tag\">Iron Deficiency Anemia Treatment<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia-symptoms\/\" rel=\"tag\">Iron Deficiency Anemia Symptoms<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/iron-deficiency-anemia\/\" rel=\"tag\">Iron Deficiency Anemia<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/tag\/anemia\/\" rel=\"tag\">anemia<\/a> <\/p>\n<div><strong>See Campaign: <\/strong><a href=\"https:\/\/www.delveinsight.com\/\" target=\"_blank\" rel=\"noopener noreferrer\">https:\/\/www.delveinsight.com\/<\/a><br \/><b>Contact Information:<\/b><br \/>Sandeep Joshi\u00a0 info@delveinsight.com\u00a0 +1(919)321-6187<\/p>\n<p><b>Tags:<\/b><br \/><a href=\"\"><\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/ips\/\" rel=\"category tag\">IPS<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/reportedtimes\/\" rel=\"category tag\">Reportedtimes<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/menafn\/\" rel=\"category tag\">Menafn<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/extended-distribution\/\" rel=\"category tag\">Extended Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/icn-internal-distribution\/\" rel=\"category tag\">iCN Internal Distribution<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/news-category\/research-newswire\/\" rel=\"category tag\">Research Newswire<\/a>, <a href=\"https:\/\/icrowdnewswire.com\/category\/language\/english\/\" rel=\"category tag\">English<\/a><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" src=\"\" alt=\"image\" width=\"400\" height=\"300\" class=\"cwdfimg\" \/><\/div>\n<div>\n<h3>Contact Information:<\/h3>\n<p>Sandeep Joshi\u00a0<\/p>\n<p> info@delveinsight.com\u00a0<\/p>\n<p> +1(919)321-6187<\/p>\n<\/p>\n<\/div>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\">The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30)<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\">Financial Market Brief<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>&nbsp; The Iron Deficiency Anemia Market Report from DelveInsight provides an in-depth understanding of Iron Deficiency Anemia, historical and forecasted epidemiology, as well as Iron Deficiency Anemia market patterns in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the Key Highlights from the Iron Deficiency Anemia Market [&hellip;]<\/p>\n<p>The post <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\">The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30)<\/a> appeared first on <a rel=\"nofollow\" href=\"https:\/\/heymuse.com\/\">Financial Market Brief<\/a>.<\/p>\n<p> <a href=\"http:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\" class=\"more-link\">Continue Reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":291,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[20],"tags":[],"class_list":["post-118457","post","type-post","status-publish","format-standard","hentry","category-press-release"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business\" \/>\n<meta property=\"og:description\" content=\"&nbsp; The Iron Deficiency Anemia Market Report from DelveInsight provides an in-depth understanding of Iron Deficiency Anemia, historical and forecasted epidemiology, as well as Iron Deficiency Anemia market patterns in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the Key Highlights from the Iron Deficiency Anemia Market [&hellip;] The post The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) appeared first on Financial Market Brief. Continue Reading &rarr;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\" \/>\n<meta property=\"og:site_name\" content=\"Business\" \/>\n<meta property=\"article:published_time\" content=\"2021-06-28T11:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png\" \/>\n<meta name=\"author\" content=\"iCrowdNewswire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"iCrowdNewswire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"6 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\",\"url\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\",\"name\":\"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business\",\"isPartOf\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png\",\"datePublished\":\"2021-06-28T11:00:00+00:00\",\"author\":{\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\"},\"breadcrumb\":{\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage\",\"url\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png\",\"contentUrl\":\"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/ipsnews.net\/business\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ipsnews.net\/business\/#website\",\"url\":\"https:\/\/ipsnews.net\/business\/\",\"name\":\"Business\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ipsnews.net\/business\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee\",\"name\":\"iCrowdNewswire\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g\",\"caption\":\"iCrowdNewswire\"},\"sameAs\":[\"https:\/\/heymuse.com\/ips\"],\"url\":\"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/","og_locale":"en_US","og_type":"article","og_title":"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business","og_description":"&nbsp; The Iron Deficiency Anemia Market Report from DelveInsight provides an in-depth understanding of Iron Deficiency Anemia, historical and forecasted epidemiology, as well as Iron Deficiency Anemia market patterns in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan. Some of the Key Highlights from the Iron Deficiency Anemia Market [&hellip;] The post The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) appeared first on Financial Market Brief. Continue Reading &rarr;","og_url":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/","og_site_name":"Business","article_published_time":"2021-06-28T11:00:00+00:00","og_image":[{"url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png","type":"","width":"","height":""}],"author":"iCrowdNewswire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"iCrowdNewswire","Est. reading time":"6 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/","url":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/","name":"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30) - Business","isPartOf":{"@id":"https:\/\/ipsnews.net\/business\/#website"},"primaryImageOfPage":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage"},"image":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage"},"thumbnailUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png","datePublished":"2021-06-28T11:00:00+00:00","author":{"@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee"},"breadcrumb":{"@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#primaryimage","url":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png","contentUrl":"https:\/\/icrowdnewswire.com\/wp-content\/uploads\/2021\/06\/5353-new20logo-01-4.png"},{"@type":"BreadcrumbList","@id":"https:\/\/ipsnews.net\/business\/2021\/06\/28\/the-current-advancements-in-the-iron-deficiency-anemia-treatment-along-with-increased-prevalence-emerging-therapies-shall-grow-the-market-size-during-the-forecast-period-2021-30\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipsnews.net\/business\/"},{"@type":"ListItem","position":2,"name":"The Current Advancements in the Iron Deficiency Anemia treatment, along with Increased Prevalence, Emerging Therapies, shall grow the market size during the forecast period (2021-30)"}]},{"@type":"WebSite","@id":"https:\/\/ipsnews.net\/business\/#website","url":"https:\/\/ipsnews.net\/business\/","name":"Business","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipsnews.net\/business\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/bde271d5882ffdcb71d1a2a961b51fee","name":"iCrowdNewswire","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipsnews.net\/business\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/aa079ec4d87ad6117c9db7a1a2cde1607ee2f869010252c2d0af346f0047b325?s=96&d=mm&r=g","caption":"iCrowdNewswire"},"sameAs":["https:\/\/heymuse.com\/ips"],"url":"http:\/\/ipsnews.net\/business\/author\/icrowdnewswire\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118457","targetHints":{"allow":["GET"]}}],"collection":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/users\/291"}],"replies":[{"embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/comments?post=118457"}],"version-history":[{"count":1,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118457\/revisions"}],"predecessor-version":[{"id":118458,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/posts\/118457\/revisions\/118458"}],"wp:attachment":[{"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/media?parent=118457"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/categories?post=118457"},{"taxonomy":"post_tag","embeddable":true,"href":"http:\/\/ipsnews.net\/business\/wp-json\/wp\/v2\/tags?post=118457"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}